ZEB2 and acute lymphoblastic leukemia: Using a conditional Zeb2 gain-of-function mouse model, we provide further evidence for a key oncogenic role of ZEB2 in the biology of immature/ETP-ALL driven by enhanced stem cell characteristics and activation of the IL7R-JAK/signal transducers and activators of transcription (STAT) signalling pathway.